Get all your news in one place.
100's of premium titles.
One app.
Start reading
AAP
AAP
Derek Rose

Oncology company reports promising cancer find

Nasdaq-listed stock of Kazia Therapeutics surged after it announced a successful cancer treatment. (David Crosling/AAP PHOTOS)

Shares in a struggling oncology company have skyrocketed after a late-stage cancer patient taking one of its drugs saw her tumours apparently disappear.

Nasdaq-listed stock of Sydney-based Kazia Therapeutics surged 51.7 per cent to a five-month high of $US8.74 ($A13.43) in after-hours trading on Tuesday after the announcement.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.